CSI Market
Sign In | Register

Nephros Inc (NEPH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access NEPH Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Nephros Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income1.34
Depreciation & amortization0.08
Amortization of Other Assets0.02
Increase (Decrease) in Deferred Revenue0.00
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase1.36
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation0.12
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), before Tax, Total0.01
Inventory F I F O Reserve Period Charge-
Inventory Fifo Reserve Period Charge-
Noncash Warrant Inducement-
Increase Decrease In License And Supply Agreement Fee Payable-
Gain Loss On Termination Of Lease-
Amortization Of Intangible Assets And License And Supply Agreement-
Amortization Of Intangible Assets License And Supply Agreement And Finance Lease Rightofuse Asset-
Amortization Of Intangibles And License And Supply Agreement-
Change In Right Of Use Asset-
Amortization Of Deferred Charges0.02
Change In Rightofuse Asset0.09
Increase Decrease In Operating Lease Liability-0.09
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable1.68
Increase (Decrease) in Accounts Payable1.06
Increase (Decrease) in Accrued Liabilities-0.48
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.08
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-6.26
Discontinued operations0.00
Net Cash flow from Operating Activities-0.99
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.29
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Equipment Financing-
Principal Payments On Finance Lease Liability-
Principal Payments On Equipment Financing-
Finance Lease Principal Payments0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations5.40
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.29
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.99
Total Cash Flow-0.70
4 historic quarters locked

Sign in to unlock the full Nephros Inc cash flow history.

Sign In Create Free Account

About Nephros Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 10, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-036851

Figures are derived from filed reports and may be restated. Historical data is subject to revision.